Create a free research account to view current pricing and place an order.
Mechanism of action
Vascular bioregulator peptide researched for endothelial and vessel-support signaling.
Half-life & pharmacokinetics
Half-life: Not standardized.
Human pharmacokinetics are not standardized. Treat exposure as short acting unless compound-specific data or formal formulation labeling indicates otherwise.
Research dosing reference
2-5 mg daily in short-course bioregulator protocols.
Dose interpretation (U-100 units)
| Target dose | U-100 units |
|---|---|
| 2 mg | 20 units |
| 5 mg | 50 units |
Units are concentration-specific - confirm against your actual reconstitution volume.
Reconstitution & concentration
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 20 mg | 2 mL BAC Water | 0.100 mg/unit |
Injection timing
Often used in short cycles; consistent daily timing is preferred for interpretation rather than acute-effect timing.
Beginner escalation
Begin at the low end of the cycle exposure and assess tolerance before extending duration or combining with additional bioregulators.
Side-effect mitigation
Monitor injection tolerance, fatigue, headache, sleep changes, mood shifts, or unexpected organ-specific symptoms. Human standardization is limited.
Stack compatibility
Bioregulators can be paired by tissue objective, but introducing one at a time improves interpretability.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
Bioregulator protocols are commonly structured as short courses. Reassess after 10-30 days and allow an off-interval before repeating unless a clinician-directed objective supports continuation.
Frequently asked questions
What is Vesugen and how does it work?
Vascular bioregulator peptide researched for endothelial and vessel-support signaling.
What is the half-life of Vesugen?
Vesugen: Not standardized. Human pharmacokinetics are not standardized. Treat exposure as short acting unless compound-specific data or formal formulation labeling indicates otherwise.
How is Vesugen reconstituted for research?
Preferred reconstitution for the 20 mg vial is 2 mL BAC Water, giving 0.100 mg/unit. Always confirm concentration math before any use. Research use only.
Is Vesugen FDA approved?
No. Vesugen is an investigational research-use-only compound - not for human or animal consumption and not FDA approved.
All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration